Fidelity Investments
DNA icon

Fidelity Investments’s Ginkgo Bioworks DNA Stock Holding History

Fidelity Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3K Sell
2,012
-1,903
-49% -$15.8K ﹤0.01% 4697
2025
Q4 		$32.5K Buy
3,915
+1,171
+43% +$12.6K ﹤0.01% 4284
2025
Q3 		$40K Buy
2,744
+228
+9% +$2.73K ﹤0.01% 4080
2025
Q2 		$28.3K Buy
2,516
+404
+19% +$3.13K ﹤0.01% 4146
2025
Q1 		$12K Sell
2,112
-288
-12% -$2.93K ﹤0.01% 4439
2024
Q4 		$23.6K Buy
2,400
+484
+25% +$4.15K ﹤0.01% 4149
2024
Q3 		$15.6K Sell
1,916
-1,785
-48% -$17.9K ﹤0.01% 4292
2024
Q2 		$49.5K Buy
3,701
+3,053
+471% +$91.1K ﹤0.01% 3629
2024
Q1 		$30.1K Sell
648
-25,882
-98% -$1.34M ﹤0.01% 3831
2023
Q4 		$1.79M Sell
26,530
-3,320
-11% -$203K ﹤0.01% 2331
2023
Q3 		$2.16M Sell
29,850
-15,333
-34% -$1.23M ﹤0.01% 2262
2023
Q2 		$3.36M Buy
45,183
+4,538
+11% +$269K ﹤0.01% 2173
2023
Q1 		$2.16M Sell
40,645
-20,570
-34% -$1.3M ﹤0.01% 2347
2022
Q4 		$4.14M Buy
61,215
+21,194
+53% +$1.95M ﹤0.01% 2169
2022
Q3 		$5M Buy
40,021
+9,892
+33% +$1.18M ﹤0.01% 2176
2022
Q2 		$2.87M Buy
30,129
+30,125
+753,125% +$3.67M ﹤0.01% 2393
2022
Q1 		$1K Buy
+4
New +$779 ﹤0.01% 4775

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments's DNA Position: Q1 2026 in Review

Fidelity Investments reduced its Ginkgo Bioworks (DNA) stake by 49% in Q1 2026, selling an estimated $15.8K and leaving 2,012 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4697.

Fidelity Investments first reported a position in DNA in Q1 2022 and has held it in 17 quarters since. The position peaked at $5M in Q3 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Fidelity Investments held 2,012 shares of Ginkgo Bioworks worth $12.3K as of Q1 2026.
  • Fidelity Investments sold 1,903 Ginkgo Bioworks shares in Q1 2026, an estimated $15.8K.
  • Ginkgo Bioworks made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4697 holding.
  • Fidelity Investments first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 17 quarters since.
  • Fidelity Investments's Ginkgo Bioworks position peaked at $5M in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.